Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Urinary Biomarkers for Neurodegenerative Diseases
Wongi Seol, Hye‐Jung Kim, Ilhong Son
Experimental Neurobiology (2020) Vol. 29, Iss. 5, pp. 325-333
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Mitochondrial Dysfunction in Neurodegenerative Diseases
Han‐Mo Yang
Cells (2025) Vol. 14, Iss. 4, pp. 276-276
Open Access | Times Cited: 2
Modular Assembly of MXene Frameworks for Noninvasive Disease Diagnosis via Urinary Volatiles
Xuyin Ding, Yecheng Zhang, Yue Zhang, et al.
ACS Nano (2022) Vol. 16, Iss. 10, pp. 17376-17388
Closed Access | Times Cited: 39
Urinary Biomarkers and Point-of-Care Urinalysis Devices for Early Diagnosis and Management of Disease: A Review
Beatriz Sequeira-Antunes, Hugo Alexandre Ferreira
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1051-1051
Open Access | Times Cited: 37
Employing nanoparticle tracking analysis of salivary neuronal exosomes for early detection of neurodegenerative diseases
Vaibhav Sharma, Fredrik Nikolajeff, Saroj Kumar
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 26
Prospective biomarkers of Alzheimer’s disease: A systematic review and meta-analysis
Ruixian Li, Ya‐Hui Ma, Lan Tan, et al.
Ageing Research Reviews (2022) Vol. 81, pp. 101699-101699
Closed Access | Times Cited: 38
Urine biomarkers for Alzheimer's disease: A new opportunity for wastewater-based epidemiology?
Arnoldo Armenta-Castro, Mónica T. Núñez-Soto, Kassandra O. Rodríguez-Aguillón, et al.
Environment International (2024) Vol. 184, pp. 108462-108462
Open Access | Times Cited: 6
Identification of novel diagnostic panel for mild cognitive impairment and Alzheimer’s disease: findings based on urine proteomics and machine learning
Yuye Wang, Yu Sun, Yu Wang, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Protein glycosylation in urine as a biomarker of diseases
Mingming Xu, Arthur L. B. Yang, Jun Xia, et al.
Translational research (2022) Vol. 253, pp. 95-107
Closed Access | Times Cited: 22
Unraveling temporal patterns of diagnostic markers and comorbidities in Alzheimer's disease: Insights from large‐scale data
Bayard Rogers
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access
Brain-Derived Exosomal Proteins as Effective Biomarkers for Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Ka Young Kim, Ki Young Shin, Keun‐A Chang
Biomolecules (2021) Vol. 11, Iss. 7, pp. 980-980
Open Access | Times Cited: 26
Alzheimer's Disease Diagnosis in the Preclinical Stage: Normal Aging or Dementia
Fahimeh Marvi, Yun-Hsuan Chen, Mohamad Sawan
IEEE Reviews in Biomedical Engineering (2024), pp. 1-18
Open Access | Times Cited: 3
Distance-based β-amyloid protein detection on PADs for the scanning and subsequent follow-up of Alzheimer's disease in human urine samples
Kawin Khachornsakkul, Anongnat Tiangtrong, Araya Suwannasom, et al.
The Analyst (2022) Vol. 147, Iss. 4, pp. 695-703
Closed Access | Times Cited: 14
Brain‐specific biomarkers in urine as a non‐invasive approach to monitor neuronal and glial damage
Konstantin Kohlhase, Franziska Frank, Christian Wilmes, et al.
European Journal of Neurology (2022) Vol. 30, Iss. 3, pp. 729-740
Open Access | Times Cited: 14
Plasma Metabolite Signature Classifies Male LRRK2 Parkinson’s Disease Patients
Dong Chen, Chandrashekhar Honrao, Leonardo O. Rodrigues, et al.
Metabolites (2022) Vol. 12, Iss. 2, pp. 149-149
Open Access | Times Cited: 13
Urine metabolomics phenotyping and urinary biomarker exploratory in mild cognitive impairment and Alzheimer’s disease
Yuye Wang, Yu Sun, Yu Wang, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 7
Microarray microRNA profiling of urinary exosomes in a 5XFAD mouse model of Alzheimer’s disease
Zhiqi Song, Yajin Qu, Yanfeng Xu, et al.
Animal Models and Experimental Medicine (2021) Vol. 4, Iss. 3, pp. 233-242
Open Access | Times Cited: 17
Is liquid biopsy mature enough for the diagnosis of Alzheimer’s disease?
Xun Gong, Hantao Zhang, Xiaoyan Liu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 12
Systematic analysis of multi-omics data reveals component-specific blood-based biomarkers for Parkinson’s disease
Tng J. W. Teddy, Barbara Wing Yan Wong, Esther H. Y. Sim, et al.
Translational Medicine Communications (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
From protein biomarkers to proteomics in dementia with Lewy Bodies
Augoustos Tsamourgelis, Peter G. Swann, Leonidas Chouliaras, et al.
Ageing Research Reviews (2022) Vol. 83, pp. 101771-101771
Open Access | Times Cited: 11
Urinary Cytokines as Potential Biomarkers of Mild Cognitive Impairment and Alzheimer’s Disease: A Pilot Study
Nazia Saiyed, Ali Yılmaz, Sangeetha Vishweswariah, et al.
Journal of Alzheimer s Disease Reports (2023) Vol. 7, Iss. 1, pp. 649-657
Open Access | Times Cited: 6
Electrochemical evaluation of magnetic reduced graphene oxide nanosheet‐modified glassy carbon electrode on dopamine electrochemical sensor for Parkinson's diagnostic application
Andri Hardiansyah, Gardin Muhammad Andika Saputra, Hikmat Hikmat, et al.
Journal of the Chinese Chemical Society (2023) Vol. 70, Iss. 8, pp. 1665-1682
Open Access | Times Cited: 6
Emerging urinary alpha-synuclein and miRNA biomarkers in Parkinson’s disease
Banabihari Giri, Marissa Seamon, Aditi Banerjee, et al.
Metabolic Brain Disease (2021) Vol. 37, Iss. 6, pp. 1687-1696
Closed Access | Times Cited: 13
Urine proteomic analysis of the rat e-cigarette model
Yuqing Liu, Ziyun Shen, Chenyang Zhao, et al.
PeerJ (2023) Vol. 11, pp. e16041-e16041
Open Access | Times Cited: 4
A better understanding of basic science may help our management of LUTS/LUTD in older persons with nocturnal polyuria and nocturia: ICI‐RS 2024
Anthony Kanai, Karel Everaert, Apostolos Apostolidis, et al.
Neurourology and Urodynamics (2024) Vol. 43, Iss. 8, pp. 2300-2307
Open Access | Times Cited: 1
Targeting for Success: Demonstrating Proof-of-Concept with Mechanistic Early Phase Clinical Pharmacology Studies for Disease-Modification in Neurodegenerative Disorders
Maurits F. J. M. Vissers, Jules A. A. C. Heuberger, Geert Jan Groeneveld
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1615-1615
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top